Summary. The non-immunoglobulin component of human milk responsible for the inhibition of Escherichia coli cell adhesion (haemagglutination) mediated by colonisation factor antigen 1 (CFAl) was determined by chromatographic fractionation of human whey proteins with Sephadex G-200, DEAE cellulose and heparin-sepharose. Pure free secretory component (fSC) and pure lactoferrin (Lo were isolated and both compounds inhibited the haemagglutination induced by E. coli CFAl+. The lowest concentrations of purified fSC and Lf able to inhibit the haemagglutination induced by E. coli strain TR50/3 CFA1' were 0-06 mg/ml and 0.1 mg/ml respectively. Commercially available lactoferrin from human milk and transferrin from human serum, which has a great structural analogy to lactoferrin, also inhibited the haemagglutination. The lowest concentrations of the commercial lactoferrin and transferrin able to inhibit the haemagglutination induced by E. coli TR50/3 CFA1+ were 0.03 mg/ml and 0-4 mg/ml, respectively. These results indicate that fSC and Lf may be important non-specific defence factors against enterotoxigenic E. coli infections.
Introduction
Enterotoxigenic Escherichia coli (ETEC) is one of the pathogens isolated most frequently from children with diarrhoea in developing c~untries.l-~ The ability of human ETEC strains to adhere to and colonise the intestinal epithelium is associated with the presence of colonisation factor antigens (CFA) in the bacterial s~r f a c e .~ Several CFAs have been characterised but CFAl is the one found most frequently in ETEC strains.5* Many epidemiological studies of diarrhoea have shown that breast feeding protects infants from intestinal infection^.^,^ The protective effect of human milk has been attributed to its immunoglobulin content, mainly to secretory immunoglobulin A (~IgA),~-ll and to non-specific defence factors such as lactoferrin (Lo, lysozyme, bifidus factor and oligosaccharides . ' 9 [12] [13] [14] [15] Lf is an 80-kDa glycoprotein, found in high concentrations in human milk,12?16 which has been shown to inhibit bacterial growth in vitro. This property is ascribed to its iron binding capacity that leads to iron deprivation for the micro-organism.l29 1 7 9 l8 It is also known that Lf binds to various microbial and this binding seems to enhance its antimicrobial capacity. 23 Moreover, study of the specific binding of Lf to enteropathogenic (EPEC), enterotoxigenic (ETEC), enteroinvasive (EIEC) and enterohaemorrhagic (EHEC) strains of E. coli showed that ETEC strains bound more Lf than the other groups of enter~pathogens.~~ The protective effect of human milk has also been thought to be due to milk components that could act as cell receptor analogues for bacterial adhesins and enterotoxins. As the cell receptors are probably glycoconjugates containing a receptor-specific oligosaccharide m~i e t y ,~~-~~ the receptor analogues should be glycocompounds. Indeed, it has been shown that fucosylated oligosaccharides are associated with the inhibition of CFA 1 -and CFA2-mediated adhesion of ETEC strains26 and inhibit localised adhesion of EPEC strain^.^ Human milk contains many glycocompounds, some of which are rich in fucosylated oligosaccharides, such as Lf and free secretory component (fSC), which are found in abundance.l2' l6, 28-30 Th e secretory component (SC) mediates the transport of sIgA into external fluids on mucosal epithelial cells, and can be found in secretions both complexed with sIgA (bound SC) or as an uncomplexed 80-kDa glycoprotein called free SC. [31] [32] [33] This study investigated a possible role for glycoproteins from human milk in the inhibition of the adhesion (haemagglutination) induced by ETEC CFA1+ strains, assaying, step by step, every fraction obtained in the chromatographic fractionation of the milk.
Materials and methods

Breast milk samples
Human milk samples were obtained from the Human Milk Bank of the Hospital Regional da Asa Sul (Brasilia DF). Aliquots of individual frozen samples were taken from at least 10 lactating mothers up to 1 month after delivery and pooled.
Fractionation of human milk
The pooled human milk was diluted with an equal volume of buffer (0.1 M Tris-HC1, pH 7.6, supplemented with 0.5 M NaC1, 1 mM phenylmethanesulphonyl fluoride, NaN, 0.1 YO and 50 mM e-amino n-caproic acid). The mixture was centrifuged at 15 000 g at 4°C for 1 h to remove lipids and cells. The middle layer was collected, acidified to pH 4.2 with acetic acid 2 % and centrifuged at 15 000 g for 40 min to remove casein. The clear supernatant fluid was removed and its pH was adjusted to neutrality with 0.1 M NaOH. Ammonium sulphate was added to 70 YO final saturation and the mixture was kept overnight at 4°C. The precipitate which formed was collected by centrifugation, dissolved in the buffer and dialysed overnight at 4°C against the buffer. The sample was then applied to a Sephadex G-200 column equilibrated with the buffer.
Purification of human milk fSC
Purification of fSC from the fractions eluted in the second peak after Sephadex G-200 chromatography was performed as described previo~sly.~~ Briefly, the fractions were pooled and dialysed against 0.0 1 M TrisHCl, pH 7.6, containing 0.05 M NaCl, and applied to a DEAE cellulose column equilibrated with the same buffer. Free SC is not retained and was eluted by washing the column with the buffer. For further purification, the eluted material was concentrated by adding (NH,),SO, to 70% final saturation. The precipitate which formed was collected by centrifugation and subsequently dissolved in and dialysed overnight at 4°C against 0.05 M Tris-HCl, pH 8.0, containing 0.2 M NaC1. This material was then applied to a heparin-sepharose affinity column equilibrated with the same buffer.
Electrophoretic procedures
The protein content of the fractions was measured by the method of Bradford.35 All fractions from the chromatographic procedures were monitored before pooling by SDS-PAGE on acrylamide 10% gels by the method of Laem~~lli.,~ Fractions from the heparin-sepharose chromatography were concentrated by precipitation with trichloro-acetic acid 10 YO before electrophoresis. Gels were stained with Coomassie Brilliant Blue G and also with ~ilver.~' Two-dimensional electrophoresis was performed3' and the gels were stained with silver.
Purification of lactoferrin
Purified Lf was obtained either as a co-purification product of the procedure used to obtain fSC, or by a single chromatographic step on a heparin-sepharose column equilibrated with 5 mM Veronal-HC1 buffer, pH 7.4, containing 0.05 M NaC1.39 Lf binds more strongly to heparin-sepharose than do the other whey proteins, and it can be eluted from the resin in a pure form with c. 0-6 M NaCl.
Inhibition assay
The test system used was agglutination of human group A erythrocytes by ETEC CFAl+-mediated a d h e s i~n .~~'~~ The ETEC CFA1+ strains used were TR 50/3, kindly provided by Dr B. C. Guth, Escola Paulista de Medicina, Sgo Paulo, Brazil and m452-C1 and CD79a provided by Dr J. Blanco, Universidade de Santiago de Compostela, Lugo, Spain. The erythrocytes were collected in sodium citrate and washed three times in saline. The bacterial strains were grown overnight in CFA medium,,, harvested, washed two or three times in saline and resuspended in saline to a concentration of 300 Klett units (measured in a Klett-Summerson photo-electric colorirneter fitted with a green filter), equivalent to 1.5 x lo9 cfu/ml.
The milk samples or fractions to be analysed were serially diluted in 25pl of saline in plastic microtitration trays (Linbro Chemical Co., Inc., New Haven, CT, USA). To each well, 25 pl of the bacterial suspension was added and the trays were first incubated for 15 min at room temperature and then kept for 2 h at 4°C. Subsequently, 25 pl of the washed erythrocytes 3 YO in saline containing D-mannose 4 % were added and the trays were kept for 2 h at 4°C. The haemagglutination pattern observed was graded from -(no agglutination) to + + + + (complete agglutination) and the 50% agglutination reaction was determined by interpolation when needed.
The highest dilution that inhibited 50% of the haemagglutination reaction was considered to be the inhibition titre of the fraction tested.
Reagents
Pharmacia, Uppsala.
The reagents were from Sigma and the resins from
Results
Our preliminary studies on adhesion inhibition induced by human milk verified that both the dialysed precipitate from human whey obtained with ammonium sulphate at 50 YO saturation, which contains most of the immunoglobulins of the milk,34 and also the supernate, were capable of inhibiting haemagglutination by the ETEC CFA1+ strains. By increasing the ammonium sulphate to 70 % saturation, the inhibition capacity was detected only in the precipitate. Furthermore, treatment of the precipitate obtained at 50 YO ammonium sulphate saturation and its supernate with trypsin increased the inhibition titre of both, whereas treatment with sodium metaperiodate decreased or abolished their inhibitory activity (results not shown). These preliminary results led us to the hypothesis that the human milk non-immunoglobulin component responsible for the inhibition was a complexed glycoprotein, because it was precipitated with ammonium sulphate, further activated by trypsin and inactivated by sodium metaperiodate.
The inhibition titre of the whey proteins obtained by precipitation at 70 YO ammonium sulphate was always > 256 for all the ETEC CFAl+ strains tested, whereas the supernate did not inhibit the reaction. Every fraction obtained from the fractionation of the human milk was tested for its capacity to inhibit haemagglutination induced by E. coli CFA1+ TR50/3 and was also analysed by SDS-PAGE.
Chromatographic fractionation
A typical profile of human whey proteins eluted from the Sephadex G-200 column is shown in fig. 1 . The fractions from the first peak (Pl-S), containing mainly s I~A ,~~ inhibited the haemagglutination induced by the ETEC CFAl+, as did the second peak (P2-S), that contained the free secretory component. This chromatographic step was repeated several times and the highest inhibition titres induced by P1-S and P2-S were always similar, varying between 64 and 128. Fractions from P1-S analysed by SDS-PAGE presented a typical profile of sIgA, showing three protein bands corresponding to the SC, heavy chain and light chain, with estimated mol. wts of 79, 57 and 21 kDa respectively ( fig. 2, lane 2) . The most inhibitory fractions from P2-S showed two main proteins of 79 kDa (corresponding to fSC) and 60 kDa ( fig. 2, lane  3) . All active fractions with the same electrophoretic pattern were pooled and applied to a DEAE cellulose column. With this procedure, B C is not retained by the resin and is eluted by washing the column with the starting
The proteins bound to the DEAE were eluted by washing the column with the same buffer supplemented with 1 M NaCl. Fig. 3 shows the elution pattern of the pooled fractions from P2-2 in ion exchange chromatography, and the titre of inhibition of some representative fractions. Most of the activity was found in the fractions containing the proteins not retained by the column (Pl-D), but a six-fold lower activity was also detected in the fractions containing the proteins that were bound to the DEAE (P2-D). Electrophoretic analyses of the active fractions of P1-D showed one main protein of c. 79 kDa (fig. 2,  lane 4) . However, when the active fractions were pooled and concentrated with ammonium sulphate at 70 YO saturation, small amounts of two more proteins of lower mol. wt were also found. This result indicated, as expected, that the main compound of P1-D was a 79-kDa protein which corresponds to fSC.
Because the most prevalent contaminant in the purification of fSC is la~toferrin,~~ which has a mol. wt of c. 80 kDa, and two-dimensional electrophoresis of the concentrated P1-D fractions showed two proteins of approximately the same mol. wt but with very distinct iso-electric points to be present ( fig. 5A) , it was thought that Lf was also present with fSC in P1-D. Therefore, the pooled and concentrated fractions of P1-D were applied to a heparin-sepharose column to remove lactoferrin and any other whey proteins basic enough to have affinity to the strongly negatively charged resin. With the procedure used, fSC was not adsorbed by the column and was eluted by washing the The unbound proteins (PI-H) were eluted in 0.05 M Tris-HC1, pH 8.0, with 0.2 M NaCl and the bound proteins were recovered with an increasing NaCl gradient (0.2 M-1 M) (---) in the same buffer; the flow rate was 9.0 ml/h. Fractions of 2.5 ml were collected and assayed for inhibition of haemagglutination induced by E. coli CFAl+ TR50/3 (-0-). column with the starting However, lactoferrin 2, lane 5). Similarly, fractions 23-25 showed a major was retained but could be removed with c. 0.6 M protein of 79 kDa corresponding to lactoferrin and NaC1.34*39 Fig. 4 shows the chromatographic profile of two other smaller proteins that could be visualised P1-D on heparin-sepharose and the inhibitory titres only by silver stain, but fractions 26-28 showed only induced by the fractions. Both the protein fractions the lactoferrin band ( fig. 2, lane 6) . These results that did not bind to the column (Pl-H) and those that showed that highly purified fSC and Lf were both able did (P2-H) inhibited haemagglutination. Electroto inhibit the haemagglutination induced by ETEC phoretic analyses of the active fractions 3-6 showed CFAl+ strains. the presence of a major protein of 79 kDa, corre-
The purity of the fSC (fraction 7) and Lf (fraction sponding to fSC, and also, in very small amounts (only 26) preparations was examined by two-dimensional revealed by silver stain) another protein of lower gel electrophoresis and silver staining ( fig. 5B and C) . mol. wt (not shown). However, fractions 7-10 showed Both fSC and Lf preparations showed the presence of only the fSC even when developed with silver stain ( fig. only one protein. The estimated PI ranges of fSC and Lf were 6-9-7-5 and 7.7-9.3 respectively, which is in good agreement with published
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The protein concentration of fraction 7 (fSC) was 1*4mg/ml, and its inhibitory titre was 24. The inhibitory titre of fraction 26 (Lf) was 12, and its protein concentration was 1.2 mg/ml. Therefore, the highest dilutions of fSC and Lf able to inhibit the haemagglutination induced by strain TR50/3 were 0.06 mg/ml and 0.1 mg/ml, respectively.
Lf in pure form and in high yield was also obtained by a single chromatographic step on heparinsepharose ( fig. 2, lane 7) . Although this Lf preparation was at least seven times more concentrated than the Lf preparation obtained by multiple chromatographic fractionation, it induced an inhibition titre at least sixfold lower. This may be explained by the differences in the procedures used for the isolation of Lf. In the single chromatographic method, Veronal-HC1 buffer was used throughout the procedure, whereas in the multiple chromatographic method Tris-HC1 buffer was used. When the Lf isolated in Verona1 buffer was dialysed against Tris-HCl, the inhibition titre of the preparation increased four-fold.
Commercial lactoferrin and transferrin
Commercially available lactoferrin from human milk and transferrin from human serum (which has a great structural analogy to lactoferrin) at 2 mg/ml and 10 mg/ml, respectively, in 0.05 M Tris-HCl, pH 7.6, were also assayed and shown to inhibit haemagglutination by ETEC CFAl+ strains. The lowest concentrations of lactoferrin and transferrin able to inhibit haemagglutination by strain TR50/3 were 0-03 mg/ml and 0.4 mg/ml, respectively. These results corroborate our finding that purified preparations of Lf had inhibitory activity and showed that transferrin also inhibited the haemagglutination, but at a higher concentration.
The minimal inhibitory concentration of lactoferrin varied with the CFAl+ strain used. The lowest concentration of lactoferrin that inhibited the haemagglutination induced by strain CD79a in our standard assay was 0.062 mg/ml, whereas the highest concentration of lactoferrin used in the assay (1 mg/ml) did not inhibit the haemagglutination induced by strain m452-C1. However, when the inhibition assay was performed with bacterial suspensions adjusted to 150 pKlett, strains CD79a and m452-Cl were inhibited by 0.02 mg/ml and 0.5 mg/ml, respectively. These results may reflect the differing ability of each strain to express CFA1.
Discussion
This study demonstrated that both fSC and Lf in human milk inhibited adhesion to erythrocytes (haemagglutination) by ETEC CFAl+ strains. Human serum transferrin, which has a great structural analogy to Lf,28 also inhibited haemagglutination but at higher concentrations than Lf.
Lf is considered to be an important non-specific defence factor against gastrointestinal infections by its iron-scavenging ability and consequent iron deprivation of micro-organisms.12* 13* ' ' 7 l8 M ore recently, specific Lf-binding receptors have been described in several bacterial p a t h~g e n s . l~-~~ Lf binding to a bacterial surface may damage the outer cell membrane and enhance the antimicrobial activity of Lf.239 45 Studying the specific binding of Lf to E. coli isolated from human intestinal infection, Naidu et a1. 24 showed that ETEC strains bound significantly more Lf than other pathogenic groups. As we found that Lf also inhibits ETEC adhesion, it may indicate that Lf binds to CFAs which are found only in ETEC strains.
Previous studiesg* 1 5 9 26 have established the association between the presence of fucosylated oligosaccharides in human milk and adhesion inhibition of ETEC and EPEC strains to eukaryotic cells. Our findings may support these reports, as the sugar chain patterns of fSC and Lf are similar and rich in fucosylated oligosaccharide 30 Some of the oligosaccharides found to inhibit bacterial adherence might even be the degradation products of glycocompounds of the milk, as it is known that human milk contains specific hydrolytic enzymes46 and fSC is very sensitive to prote~lysis.~~* 34 Furthermore, fucosecontaining glycopeptides from Lf were shown to inhibit the adherence of Shigella JEexneri to intestinal cells . 47 There is little information about the role of fSC in secretions but some workers suggest that it may have a protective role against diarrhoea.48* 49 This report showed that fSC inhibited the adherence of ETEC strains in vitro, indicating that this compound may be an important non-specific defence factor because it is also found in intestinal secretion~,~~ hence providing protection for the mucous membranes which are the initial target in most infections.
We, as well as other author^,^'^^ have verified that the immunoglobulin fraction (P1 -S) also inhibited bacterial adherence. As the main immunoglobulin in human milk is sIgA and its molecule contains covalently bound SC, the inhibitory effect of sIgA may be partially due to the bound SC. In this context, Lf is a strongly basic protein which has been shown to
